Evidence map›Paper›PMID 25984973›Full record

ArticleScientific reports2015

Serum IGFBP7 levels associate with insulin resistance and the risk of metabolic syndrome in a Chinese population.

Yi Liu, Minliang Wu, Jie Ling, Libing Cai, Dandan Zhang, Harvest F Gu, Hao Wang, Yimin Zhu, Maode Lai

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Yi LiuDepartment of Epidemiology &Biostatistics, Zhejiang University School of Public Health, Hangzhou 310058, China.
Minliang WuDepartment of Laboratory, the second Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou 310003, China.
Jie LingDepartment of Epidemiology &Biostatistics, Zhejiang University School of Public Health, Hangzhou 310058, China.
Libing CaiThird Hospital of Xiaoshan, Hangzhou 311251, China.
Dandan ZhangDepartment of Pathology, Zhejiang University School of Medicine, Hangzhou 310058, China.
Harvest F GuRolf Luft Research Center for Diabetes and Endocrinology, Department of Molecular Medicine and Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm SE-171 76, Sweden.
Hao WangDepartment of Pathology, Zhejiang University School of Medicine, Hangzhou 310058, China.
Yimin ZhuDepartment of Epidemiology &Biostatistics, Zhejiang University School of Public Health, Hangzhou 310058, China.
Maode LaiDepartment of Pathology, Zhejiang University School of Medicine, Hangzhou 310058, China.
Zhejiang University · CNKarolinska Institutet · SESecond Affiliated Hospital of Zhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metabolic syndrome (MetS), one of the major public health concerns, is regarded as the "common soil" of incidence of common chronic diseases and may increase the risk of type 2 diabetes. The predominant underlying mechanism of MetS is insulin resistance (IR). Additionally, previous studies have indicated that IGFBP7 has high affinity of binding with insulin and might induce IR. The objective of this study was to firstly evaluate the associations of serum IGFBP7 levels with IR and MetS with a relatively large sample and population based design. In a population based MetS case-control study, HOMA-IR was used to evaluate the insulin sensitivity and serum IGFBP7 levels were determined with chemiluminescence-linked immunoassay. As a result, the subjects of MetS and IR had higher serum levels of IGFBP7 than control healthy subjects. High serum IGFBP7 levels increased the risk of MetS and IR. Serum IGFBP7 levels were also found to be significantly correlated with metabolic-associated parameters of Waist-to-hip ratio (WHR), HDL and LDL. These findings suggest that serum IGFBP7 levels are associated with IR and MetS, providing new insight into the mechanism of IR and Mets. IGFBP7 may be a potential interventional target for IR and Mets.

Indexed as

Insulin ResistancePopulation SurveillanceAdultAgedBiomarkersCase-Control StudiesChinaFemaleHumansInsulin-Like Growth Factor Binding ProteinsMaleMetabolic SyndromeMiddle AgedRiskBiomarkersinsulin-like growth factor binding protein-related protein 1Insulin-Like Growth Factor Binding Proteins

Identifiers

PMID25984973
PMCPMC4650783
OpenAlexW2268730974

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.